Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region?

Curr Vasc Pharmacol. 2022;20(4):311-312. doi: 10.2174/1570161119666210921093735.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticholesteremic Agents* / adverse effects
  • Balkan Peninsula
  • Cholesterol, LDL
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Hypercholesterolemia*

Substances

  • Cholesterol, LDL
  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors